In the training cohort of NASH patients, significantly high DNA methylation and low expression levels were noted for ApoF and THOP1, while a low DNA methylation and high expression level was observed for BICC1 (p < 0.001) (Figure 4e–j). The gene discussed is APOF; the disease is metabolic dysfunction-associated steatohepatitis.